Literature DB >> 3736079

Late results after left-sided cardiac valve replacement in children.

A Milano, P R Vouhé, F Baillot-Vernant, P Donzeau-Gouge, F Trinquet, P M Roux, F Leca, J Y Neveux.   

Abstract

Selection of types of cardiac valve substitutes for children remains controversial. Between 1976 and 1984, 166 children, 15 years of age or younger, underwent aortic (N = 53) or mitral valve replacement (N = 90) or both (N = 23). Biological prostheses were used in 84 patients and mechanical prostheses in 71; both a mitral bioprosthesis and an aortic mechanical valve were used in 11 patients. The overall early mortality was 9%. Mean follow-up intervals were 4.1 years for the bioprosthesis group, 3.3 years for the mechanical valve group, and 3.5 years for the group receiving both. The 7 year survival rates (+/- standard error) were 63% +/- 6% in the bioprosthesis group and 70% +/- 7% in the mechanical valve group (p = NS). After aortic valve replacement the 7 year survival rates were 66% +/- 14% (bioprosthesis group) and 77% +/- 9% (mechanical valve group) (p = NS); after mitral valve replacement the rates were 65% +/- 7% (bioprosthesis group) and 54% +/- 17% (mechanical valve group) (p = NS). The incidence of thromboembolic events was 0.6% +/- 0.4% per patient-year in the bioprosthesis group (none after aortic valve replacement, 0.8% +/- 0.6% per patient-year after mitral valve replacement) and 1.4% +/- 0.8% per patient-year in the mechanical valve group (0.7% +/- 0.7% per patient-year after aortic valve replacement, 4.0% +/- 2.8% per patient-year after mitral valve replacement) (p = NS). The linearized rates of reoperation were 10.4% +/- 1.8% per patient-year (bioprosthesis group) and 2.3% +/- 1.0% per patient-year (mechanical valve group) (p less than 0.001). The 7 year probability rates of freedom from all valve-related complications were 43% +/- 6% in the bioprosthesis group and 86% +/- 4% in the mechanical valve group (p less than 0.001). In the aortic position, a mechanical adult-sized prosthesis can always be implanted, and satisfactory long-term results can be anticipated. In the systemic atrioventricular position, the results are less than satisfactory with either type of prosthesis; every effort should be made to preserve the natural valve of the child.

Entities:  

Mesh:

Year:  1986        PMID: 3736079

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  7 in total

1.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Fifteen-year experience with 1678 Hancock porcine bioprosthetic heart valve replacements.

Authors:  L H Cohn; J J Collins; V J DiSesa; G S Couper; P S Peigh; W Kowalker; E Allred
Journal:  Ann Surg       Date:  1989-10       Impact factor: 12.969

3.  Mitral valve replacement in children: mortality, morbidity, and haemodynamic status up to medium term follow up.

Authors:  C van Doorn; R Yates; V Tsang; M deLeval; M Elliott
Journal:  Heart       Date:  2000-12       Impact factor: 5.994

4.  Infant Ross procedure for recurrent aortic stenosis.

Authors:  M Runciman; I Ostman-Smith; S Westaby
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

5.  Repair of congenital malformations of the mitral valve in children: early and long-term results in 34 cases.

Authors:  G Stellin; A Mazzucco; U Bortolotti; A Milano; G Faggian; O Milanesi; V Gallucci
Journal:  Tex Heart Inst J       Date:  1989

6.  Reassessment of usefulness of porcine heterografts in mitral position in children.

Authors:  P S Rao; L Solymar; M E Fawzy; G Guinn
Journal:  Pediatr Cardiol       Date:  1991-07       Impact factor: 1.655

7.  Pulmonary autograft replacement in children. The ideal solution?

Authors:  R C Elkins; K Santangelo; J D Randolph; C J Knott-Craig; P Stelzer; W M Thompson; J D Razook; K E Ward; E D Overholt
Journal:  Ann Surg       Date:  1992-09       Impact factor: 12.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.